Treventis
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
60 Leonard Ave, Toronto, Ontario, M5T 0S...Phone Number
(416) 603-5800Website
www.treventis.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Treventis
Treventis Corporation is a Canadian biotech start-up focused on treating and preventing protein misfolding diseases through its proprietary Common Conformational Morphology (CCM) technology. The company utilizes a patented discovery engine to identify druggable active sites in misfolded protein targets, with a lead program in partnership with Takeda aimed at developing anti-misfolding small molecules for Alzheimer's disease. Treventis also has ongoing efforts funded by the U.S. Department of Defense in oncology and other neurodegenerative diseases, showcasing the versatility of its technology platform. Their therapeutic areas include Alzheimer's disease, ALS, Parkinson's disease, and cancer.Explore more
Treventis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Treventis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Treventis recently announced quarterly report
Check out if Treventis is spiking on competitors!
Product Launch: Get notified when Treventis launches new products
Treventis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Treventis
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Treventis has new funding data
Click to see if Treventis had a recent Job posting/layoffs
Check if Treventis has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Treventis
Find 3 more new buyers
Compare Similar Companies to Treventis
Compare insights from companies similar to Treventis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Treventis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Treventis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Treventis.
Treventis financials insights
Gather financial insights about Treventis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$4.4M
Treventis Tech Stack
A closer look at the technologies used by Treventis
Treventis News & Media
Treventis Awarded $2.97M Grant from the U.S. Department of Defense
Funds for Development of Its Anti-Tau Drug Against Neurodegenerative Diseases BERNVILLE, Pa., Oct. 18, 2022 /PRNewswire/ -- Treventis Corporation, a privately held biotechnology company, announced today that their proposal to preclinically develop a small molecule anti-tau misfolding drug...Treventis Diagnostics highlighted in recent press articles
HALIFAX, Nova Scotia, Jan. 30, 2018 /PRNewswire/ -- The Treventis diagnostics program in Alzheimer's disease, headed by neurologist and medicinal chemist Dr. Sultan Darvesh, was recently featured in two news articles:...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Treventis
Sign Up For FreeTo access detailed company insights
Treventis Corporation is a Canadian biotech start-up focused on treating and preventing protein misfolding diseases through its proprietary Common Conformational Morphology (CCM) technology. The company utilizes a patented discovery engine to identify druggable active sites in misfolded protein targets, with a lead program in partnership with Taked... Read More
